{
    "clinical_study": {
        "@rank": "107470", 
        "arm_group": {
            "arm_group_label": "Metoprolol to Nebivolol", 
            "description": "Patients with high blood pressure (hypertension) who were continuously treated with metoprolol for a minimum of 6 months prior to switching to nebivolol. Patients were then continuously treated with nebivolol for a minimum of 6 months."
        }, 
        "brief_summary": {
            "textblock": "This is a retrospective data analysis of patients with high blood pressure (hypertension)\n      who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a\n      minimum of 6 month to treat hypertension. These patients will be identified from a large\n      medical claims database. This study tests the hypothesis (alternative, higher or lower) that\n      average patient monthly health care administrative cost changes after switching from\n      metoprolol to nebivolol."
        }, 
        "brief_title": "Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be at least 18 years old at initiation of metoprolol (or first date on metoprolol\n             treatment between 2007 and 2011)\n\n          -  Had one or more inpatient or outpatient claims with a primary or non-primary\n             diagnosis of hypertension (ICD-9-CM 401.xx-405.xx)\n\n          -  Received nebivolol treatment continuously (defined as supply gap <30 days) for at\n             least 6 months after initiation\n\n          -  Received metoprolol treatment continuously for at least 6 months prior to switching\n             to (initiation of) nebivolol (defined as metoprolol was discontinued whereas a\n             prescription for nebivolol was filled)\n\n          -  Had at least 12 months of continuous enrollment (as verified using enrollment file):\n             6 month prior to nebivolol initiation and 6 months following nebivolol initiation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patents treated for hypertension during the period of 2007-2011 in the United States."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758263", 
            "org_study_id": "NEB-HE-200"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metoprolol to Nebivolol", 
                "description": "Metoprolol, oral administration", 
                "intervention_name": "Metoprolol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Metoprolol to Nebivolol", 
                "description": "Nebivolol, oral administration", 
                "intervention_name": "Nebivolol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Metoprolol", 
                "Nebivolol", 
                "Metoprolol succinate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Hypertension", 
            "Health Care Cost", 
            "Monthly health care cost"
        ], 
        "lastchanged_date": "December 26, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jersey City", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07311"
                }, 
                "name": "Forest Investigative Site 0"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment: A Retrospective Database Analysis", 
        "overall_official": {
            "affiliation": "Forest Laboratories", 
            "last_name": "Stephanie Chen, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The average per patient monthly health care cost for the pre-specified hypertensive target study population during the 6 months before and after switching from metoprolol to nebivolol", 
            "measure": "Patient monthly health care cost", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Estimate the average per patient monthly number of out-patient visits for the pre-specified hypertensive target study population during the 6 months before and after switching from metoprolol to nebivolol.", 
                "measure": "Number of monthly out-patient visits", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Estimate of the average monthly number of Emergency Room (ER) visits per patient for the pre-specified hypertensive target study population during the 6 months before and after switching from metoprolol to nebivolol.", 
                "measure": "Monthly Emergency Room visits per patient", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Estimate of the average monthly number of hospitalizations per patient for the pre-specified hypertensive target study population during the 6 months before and after switching from metoprolol to nebivolol.", 
                "measure": "Monthly hospitalizations per patient", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Forest Laboratories", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Forest Laboratories", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}